• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

拔牙术后双膦酸盐相关颌骨骨坏死的发生情况。

Occurrence of bisphosphonate-related osteonecrosis of the jaw after surgical tooth extraction.

作者信息

Saia Giorgia, Blandamura Stella, Bettini Giordana, Tronchet Anita, Totola Andrea, Bedogni Giorgio, Ferronato Giuseppe, Nocini Pier Francesco, Bedogni Alberto

机构信息

Unit of Maxillofacial Surgery, University of Padova, Padua, Italy.

出版信息

J Oral Maxillofac Surg. 2010 Apr;68(4):797-804. doi: 10.1016/j.joms.2009.10.026.

DOI:10.1016/j.joms.2009.10.026
PMID:20307765
Abstract

PURPOSE

To evaluate the occurrence of bisphosphonate-related osteonecrosis of the jaw (BRONJ) in patients exposed to nitrogen-containing bisphosphonates (NBPs) requiring surgical tooth extraction.

PATIENTS AND METHODS

Sixty high-risk patients exposed to NBPs underwent surgical tooth extraction with bone biopsy and were treated with a 7-day cycle of oral antibiotics and discontinuation of NBPs for 1 month. BRONJ was defined as the occurrence of any BRONJ stage (0-3) at 3, 6, or 12 months of follow-up. Inferential analysis was performed on a per-bone (maxilla and/or mandible) basis (n = 72). The time to BRONJ was calculated, and age, gender, cancer diagnosis, and baseline osteomyelitis were evaluated as potential predictors. Exact logistic regression was used to model the time-to-outcome relationship, and hazard rates were calculated from logistic probabilities.

RESULTS

BRONJ was detected at 3 months' follow-up in 4 bones and at 6 months in 1 further bone. In the whole cohort of bones, the hazard rate of BRONJ was 5.6% at 3 months and 1.5% at 6 months. Baseline osteomyelitis was a strong risk factor for BRONJ development (odds ratio, 156.96; exact 95% confidence interval, 18.99 to infinity; exact P < .0001).

CONCLUSION

In this 12-month follow-up study, BRONJ was a rare outcome in high-risk NBP users who underwent surgical tooth extraction. Moreover, baseline osteomyelitis was a very strong risk factor for BRONJ development.

摘要

目的

评估接受含氮双膦酸盐(NBP)治疗且需要进行外科拔牙的患者发生双膦酸盐相关颌骨坏死(BRONJ)的情况。

患者与方法

60例暴露于NBP的高危患者接受了外科拔牙及骨活检,并接受为期7天的口服抗生素治疗,同时停用NBP 1个月。BRONJ定义为在随访3、6或12个月时出现任何BRONJ分期(0 - 3期)。基于每块骨(上颌骨和/或下颌骨)进行推断性分析(n = 72)。计算BRONJ的发生时间,并评估年龄、性别、癌症诊断和基线骨髓炎作为潜在预测因素。采用精确逻辑回归对结局时间关系进行建模,并根据逻辑概率计算风险率。

结果

在随访3个月时,4块骨检测到BRONJ,6个月时又有1块骨检测到。在整个骨队列中,BRONJ的风险率在3个月时为5.6%,6个月时为1.5%。基线骨髓炎是BRONJ发生的一个强风险因素(优势比,156.96;精确95%置信区间,18.99至无穷大;精确P <.0001)。

结论

在这项为期12个月的随访研究中,接受外科拔牙的高危NBP使用者中BRONJ是一种罕见的结局。此外,基线骨髓炎是BRONJ发生的一个非常强的风险因素。

相似文献

1
Occurrence of bisphosphonate-related osteonecrosis of the jaw after surgical tooth extraction.拔牙术后双膦酸盐相关颌骨骨坏死的发生情况。
J Oral Maxillofac Surg. 2010 Apr;68(4):797-804. doi: 10.1016/j.joms.2009.10.026.
2
Tooth extraction in patients receiving oral or intravenous bisphosphonate administration: A trigger for BRONJ development?接受口服或静脉注射双膦酸盐治疗的患者拔牙:引发药物性颌骨坏死的诱因?
J Craniomaxillofac Surg. 2015 Jul;43(6):847-54. doi: 10.1016/j.jcms.2015.03.039. Epub 2015 Apr 10.
3
Nationwide survey for bisphosphonate-related osteonecrosis of the jaws in Japan.日本全国范围内双膦酸盐相关颌骨坏死的调查。
J Oral Maxillofac Surg. 2011 Nov;69(11):e364-71. doi: 10.1016/j.joms.2011.03.051. Epub 2011 Jul 23.
4
Incidence of bisphosphonate-related osteonecrosis of the jaw in high-risk patients undergoing surgical tooth extraction.接受拔牙手术的高危患者中双膦酸盐相关颌骨坏死的发生率。
J Craniomaxillofac Surg. 2015 May;43(4):510-4. doi: 10.1016/j.jcms.2015.02.018. Epub 2015 Mar 9.
5
[A case of bisphosphonate-related osteonecrosis of the jaw in a patient who had received intravenous bisphosphonates].[一例接受静脉注射双膦酸盐治疗的患者发生双膦酸盐相关颌骨坏死]
Gan To Kagaku Ryoho. 2014 Feb;41(2):225-7.
6
Radiographic findings in bisphosphonate-treated patients with stage 0 disease in the absence of bone exposure.在无骨暴露的0期疾病双膦酸盐治疗患者中的影像学表现。
J Oral Maxillofac Surg. 2010 Sep;68(9):2232-40. doi: 10.1016/j.joms.2010.05.003.
7
Serologic bone markers for predicting development of osteonecrosis of the jaw in patients receiving bisphosphonates.用于预测接受双膦酸盐治疗患者颌骨坏死发生情况的血清学骨标志物。
J Oral Maxillofac Surg. 2010 Sep;68(9):2241-7. doi: 10.1016/j.joms.2010.05.043.
8
Long-term oral bisphosphonates delay healing after tooth extraction: a single institutional prospective study.长期口服双膦酸盐会延迟拔牙后愈合:单机构前瞻性研究。
Osteoporos Int. 2018 Oct;29(10):2315-2321. doi: 10.1007/s00198-018-4621-7. Epub 2018 Jul 2.
9
Intravenous bisphosphonate-related osteonecrosis of the jaw: bone scintigraphy as an early indicator.静脉注射双膦酸盐相关颌骨坏死:骨闪烁显像作为早期指标
J Oral Maxillofac Surg. 2009 Jul;67(7):1363-72. doi: 10.1016/j.joms.2009.03.005.
10
Zoledronic acid delays wound healing of the tooth extraction socket, inhibits oral epithelial cell migration, and promotes proliferation and adhesion to hydroxyapatite of oral bacteria, without causing osteonecrosis of the jaw, in mice.唑来膦酸延迟拔牙窝的伤口愈合,抑制口腔上皮细胞迁移,并促进口腔细菌向羟基磷灰石的增殖和黏附,而不会导致小鼠下颌骨坏死。
J Bone Miner Metab. 2010 Mar;28(2):165-75. doi: 10.1007/s00774-009-0128-9. Epub 2009 Oct 31.

引用本文的文献

1
Medication-Related osteonecrosis of the jaw involving dental implants: A 16-Year observational study in a single cancer center.与药物相关的颌骨坏死累及牙种植体:在单一癌症中心进行的16年观察性研究。
Clin Oral Investig. 2025 Sep 2;29(9):436. doi: 10.1007/s00784-025-06519-7.
2
What is the appropriate antibiotic administration to prevent MRONJ development after tooth extraction?拔牙后预防药物相关性颌骨坏死(MRONJ)发生的合适抗生素给药方式是什么?
J Bone Miner Metab. 2025 Jul 2. doi: 10.1007/s00774-025-01617-8.
3
A case series and review of canine idiopathic osteonecrosis of the jaw.
犬颌骨特发性骨坏死的病例系列及综述
Front Vet Sci. 2025 May 27;12:1614645. doi: 10.3389/fvets.2025.1614645. eCollection 2025.
4
Medication related osteonecrosis (MRONJ) in the management of CTIBL in breast and prostate cancer patients. Joint report by SIPMO AND SIOMMMS.乳腺癌和前列腺癌患者CTIBL管理中的药物相关性骨坏死(MRONJ)。SIPMO和SIOMMMS联合报告
J Bone Oncol. 2024 Dec 16;50:100656. doi: 10.1016/j.jbo.2024.100656. eCollection 2025 Feb.
5
Reduction of MRONJ risk after exodontia by virtue of ozone infiltration: A randomized clinical trial.通过臭氧浸润降低拔牙后 MRONJ 的风险:一项随机临床试验。
Oral Dis. 2024 Nov;30(8):5183-5194. doi: 10.1111/odi.15006. Epub 2024 May 29.
6
Bisphosphonates and Their Connection to Dental Procedures: Exploring Bisphosphonate-Related Osteonecrosis of the Jaws.双膦酸盐及其与牙科手术的关联:探索双膦酸盐相关颌骨坏死
Cancers (Basel). 2023 Nov 10;15(22):5366. doi: 10.3390/cancers15225366.
7
Three-dimensional clinical assessment for MRONJ risk in oncologic patients following tooth extractions.三维临床评估在肿瘤患者拔牙后 MRONJ 风险中的应用。
Dentomaxillofac Radiol. 2023 Nov;52(8):20230238. doi: 10.1259/dmfr.20230238. Epub 2023 Oct 24.
8
Comparison of Different Antibiotic Regimes for Preventive Tooth Extractions in Patients with Antiresorptive Intake-A Retrospective Cohort Study.抗吸收药物摄入患者预防性拔牙不同抗生素治疗方案的比较——一项回顾性队列研究
Antibiotics (Basel). 2023 Jun 1;12(6):997. doi: 10.3390/antibiotics12060997.
9
Location and Gender Differences in Osteonecrosis of the Jaws in Patients Treated with Antiresorptive and Antineoplastic Drugs Undergoing Dentoalveolar Surgical, Systematic Review with Meta-Analysis and Trial Sequential Analysis.接受抗吸收和抗肿瘤药物治疗的患者在牙槽外科手术中发生颌骨骨坏死的部位和性别差异:系统评价、荟萃分析和试验序贯分析
J Clin Med. 2023 May 5;12(9):3299. doi: 10.3390/jcm12093299.
10
The Use of Hydroxyapatite Loaded with Doxycycline (HADOX) in Dentoalveolar Surgery as a Risk-Reduction Therapeutic Protocol in Subjects Treated with Different Bisphosphonate Dosages.将载有强力霉素的羟磷灰石(HADOX)用于牙牙槽外科,作为不同双膦酸盐剂量治疗的受试者的风险降低治疗方案。
Medicina (Kaunas). 2022 Dec 27;59(1):46. doi: 10.3390/medicina59010046.